Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 369

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonist

Open access
Camilleri, Mayer, Drossman, Heath, Dukes, Mcsorley, Kong, Mangel, Northcutt·1999·Alimentary Pharmacology & Therapeutics

Abstract

Background: : No currently available treatment provides consistent relief of irritable bowel syndrome. Colonic sensory and motor function are modulated partly through 5HT 3‐receptors. Aim: : To evaluate effects of the 5HT 3‐receptor antagonist, alosetron, in irritable bowel syndrome. Methods: : Randomized, double‐blind, placebo‐controlled, dose‐ranging (1, 2, 4, 8 mg b.d. alosetron), 12‐week trial in 370 patients with diarrhoea‐predominant or alternating constipation and diarrhoea irritable bowel syndrome. Weekly measurement of adequate relief was the key end‐point; other irritable bowel syndrome symptoms were collected daily using an electronic phone system. Results: : Alosetron (1 mg or 2 mg b.d.) significantly (P < 0.05 vs. placebo) increased the proportion of females, but not males, reporting adequate relief. Stool consistency, frequency and percentage days with urgency improved over placebo (P < 0.05) within the first month with all doses of alosetron, and persisted throughout the trial with all doses in female patients. With 1 mg b.d. alosetron, females had improved stool consistency and urgency within the first week, and adequate relief and improved stool frequency within the first 2 weeks. There was no consistent improvement in bowel function among male patients. Conclusion: : In female irritable bowel syndrome patients with predominant diarrhoea or alternating constipation and diarrhoea, alosetron is effective in treatment of abdominal pain and discomfort and bowel‐related symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.1999.00610.x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 369

Metadata

Authors
Camilleri, Mayer, Drossman, Heath, Dukes, Mcsorley, Kong, Mangel, & Northcutt
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
1999-09
Volume
13
Issue
9
Pages
1149-1159
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2042335480
Cited by
369
References
33
FWCI
18.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonist. https://app.cochat.ai/papers/10.1046/j.1365-2036.1999.00610.x
The paper
Camilleri, Mayer, Drossman, Heath, Dukes, Mcsorley, Kong, Mangel, & Northcutt. (1999). Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonist. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1999.00610.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.